vs 9,698 other HR bills in the 117th — cohort avg 63d
Summary
Second Chance at Life Act of 2021 This bill requires abortion providers to disclose information about the possibility of reversing a medication abortion. This is a procedure that uses a medication regimen to terminate a pregnancy, typically with a two-drug protocol. Providers must inform patients that it may be possible to reverse the effects of a medication abortion after taking the first drug. They must also let patients know that more information and assistance is available on the Department of Health and Human Services (HHS) website. At least 24 hours before the procedure, the provider must share this information with the patient in person or by telephone. The provider must also include the information in written discharge instructions after the first drug is dispensed. The bill sets out an exception to these notification requirements when an abortion is necessary to resolve a physical injury or condition that threatens the life of the woman. The provider must document the circumstances giving rise to the exception in the patient's medical file. Furthermore, providers must post signs with this information in their offices or facilities, and HHS must maintain information about reversing medication abortions on its website.
Lobbying filings that explicitly cite this bill (9)
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Cited source text, amounts, lobbyists, and targets
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Abortion-related provisions pertaining to modifying PL 111-148 are reported on the HCR (Health Issues) page. Contacts in support of the Pain-Capable Unborn Child Protection Act (S. 61/H.R. 1080), to protect pain-capable unborn children beginning at 20 weeks fetal age. Contacts in support of the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of the Dismemberment Ban Act (H.R. 558) to prohibit a physician from knowingly performing a dismemberment abortion. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 619/ S.123), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age, and ensure that such child is immediately admitted to a hospital, including a urging signing of a discharge petition. Contacts in support of the Conscience Protection Act (S.401), to enhance federal remedies for health-care providers who face government-based discrimination for non-participation in abortion. Contacts in support of similar House legislation. Contacts regarding legislation to defund certain abortion providers (S. 139/H.R. 541/S.1881/H.R. 188/S.95/H.R.2619) to prohibit federal funding to entities that do not certify the entities will not perform or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding the Pregnant Workers Fairness Act (H.R. 1065). No position taken. Contacts regarding the Violence Against Women Reauthorization Act of 2021 (H.R. 1620). No position taken. Contacts regarding legislation to improve abortion reporting (H.R. 581/H.R.343/H.R. 6702 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 705 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.552) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.243/S.88/H.R. 500) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in support of legislation dealing with the disposal of fetal remains (H.R. 555/ H.R. 620/S.293). Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486. Contacts in support of the Down Syndrome Discrimination by Abortion Prohibition Act (S.75/ H.R.532) to prohibit abortions on the basis that the unborn child has or may have Down syndrome. Contacts in support of the Support and Value Expectant (SAVE) Moms and Babies Act of 2021 (S.78 /H.R. 554) to prevent labeling changes for already approved abortion drugs; prevents providers from dispensing these abortion drugs remotely, by mail, or via telemedicine; and prevent the Food and Drug Administration (FDA) from approving new chemical abortion drugs. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act of 2021 (H.R.626/S. 3252) to prohibit abortionists from performing chemical abortions without being physically present. Contacts explaining nonsupport for the Life at Conception Act (S.99/H.R. 1011) and the Sanctity of Human Life Act (H.R. 877), and similar legislation based on lack of clarity and erroneous legal premises. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 109/H.R.627/H.R.2223/H.R.627/S.16) to prohibit the knowing transportation of a minor across a state line, with the intent that the minor obtains an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision. Contacts in support of the Informed Consent Act (H.R. 1382/S.446) to criminalize any abortion or sterilization procedure performed without the informed consent of the person on whom such procedure is performed, and for other purposes. Contacts in support of the Protecting Life in Crisis Act (H.R. 28/S.87) which would extend existing Hyde Amendment protections to any COVID-19-related healthcare provisions. Contacts in support of PRENDA (S.86) to prohibit sex-selection abortions. Contacts in support of the Protecting Life and Integrity in Research Act of 2021(H.R. 563/S.77) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus, which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.92/H.R. 18). Contacts in support of defeating a Previous Question in order to initiate a procedure to provide for the immediate consideration of HR 18, the No Taxpayer Funding for Abortion Act, sponsored by Rep. Chris Smith (R-NJ). The Smith bill would make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 3755/H.R.8296) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts regarding the Family Violence Prevention Act (H.R. 2119) in regard to abortion expanding provisions. Contacts in opposition to changes to Title X regulations which bar grantees from co-locating with abortion clinics or referring clients for abortions including support of a CRA overturning Biden administration regulation (S.J.Res. 41/H.J.Res. 76). Contacts in support of the Simon Crosier Act (H.R. 5656) which requires certain policies to be in place relating to do-not-resuscitate orders or similar physicians orders for unemancipated minors receiving services. Contacts in support of the Pregnancy Loss Mental Health Research Act of 2021 (H.R. 5995) to provide research on, and services for, individuals with clinical mental health complications following a pregnancy loss. Contacts in support of Stopping Traffickers and Their Accomplices Act of 2022 (H.R.6536) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regard to Data Mapping to Save Moms Lives Act (H.R.1218) and impact on abortion reporting. No position taken this quarter. Contacts in support of the Protecting Girls with Turner Syndrome Act of 2022 (H.R.7179) which would prohibit the performance of an abortion on an unborn child due to a diagnosis of Turner syndrome. Contacts in regard to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to legislation (not introduced) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs and changes to REMS regarding chemical abortion drugs. Contacts in regard to the Bipartisan Safer Communities Act (S.2938). No position taken. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (S. 4868/H.R. 8851 Providing for Life Act, H.R. 8384/S.4541 Standing with Moms Act, and others). Contacts in regards legislation to respond to violence directed at pro-life organizations, pregnancy resource centers, and churches related to Supreme Court action on the Dobbs case. Contacts in opposition to the Build Back Better reconciliation bill (H.R. 5376). H.R. 5376 contains numerous provisions to fund elective abortion in violation of the longstanding principles of the Hyde Amendment, would mandate abortion funding in Affordable Care Act (Obamacare) plans in states that did not expand Medicaid in 2024, and direct billions of dollars to various public health grants without Hyde Amendment protections. Contacts in opposition to the Right to Contraception Act (H.R. 8373) which includes provisions related to the funding of abortion providers and includes language that could permit the use of drugs to induce an abortion weeks or months into a pregnancy. Contacts in opposition to H. Res. 1434 dealing with the preemption of state law in regard to abortion drugs. Contacts regarding H. R. 6878, the Pregnant Women in Custody Act, as it relates to travel for abortion. No position taken.
Cited source text, amounts, lobbyists, and targets
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Abortion-related provisions pertaining to modifying PL 111-148 are reported on the HCR (Health Issues) page. Contacts in support of the Pain-Capable Unborn Child Protection Act (S. 61/H.R. 1080), to protect pain-capable unborn children beginning at 20 weeks fetal age. Contacts in support of the Protecting Pain-Capable Unborn Children from Late-Term Abortions Act (S. 4840/H.R. 8814), to protect pain-capable unborn children beginning at 15 weeks of pregnancy. Contacts in support of the Dismemberment Ban Act (H.R. 558) to prohibit a physician from knowingly performing a dismemberment abortion. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 619/ S.123), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age, and ensure that such child is immediately admitted to a hospital, including a urging signing of a discharge petition. Contacts in support of the Conscience Protection Act (S.401), to enhance federal remedies for health-care providers who face government-based discrimination for non-participation in abortion. Contacts in support of similar House legislation. Contacts regarding legislation to defund certain abortion providers (S. 139/H.R. 541/S.1881/H.R. 188/S.95/H.R.2619) to prohibit federal funding to entities that do not certify the entities will not perform, or provide any funding to any other entity that performs, an abortion, with certain exceptions. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding the Pregnant Workers Fairness Act (H.R. 1065). No position taken. Contacts regarding the Violence Against Women Reauthorization Act of 2021 (H.R. 1620). No position taken. Contacts regarding legislation to improve abortion reporting (H.R. 581/H.R.343/H.R. 6702 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 705 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.552) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in support of legislation (H.R.243/S.88/H.R. 500) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in support of legislation dealing with the disposal of fetal remains (H.R. 555/ H.R. 620/S.293). Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486. Contacts in support of the Down Syndrome Discrimination by Abortion Prohibition Act (S.75/ H.R.532 ) to prohibit abortions on the basis that the unborn child has or may have Down syndrome. Contacts in support of the Support And Value Expectant (SAVE) Moms and Babies Act of 2021 (S.78 /H.R. 554) to prevent labeling changes for already approved abortion drugs; prevents providers from dispensing these abortion drugs remotely, by mail, or via telemedicine; and prevent the Food and Drug Administration (FDA) from approving new chemical abortion drugs. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act of 2021 (H.R.626/S. 3252) to prohibit abortionists from performing chemical abortions without being physically present. Contacts explaining nonsupport for the Life at Conception Act (S.99/H.R. 1011) and the Sanctity of Human Life Act (H.R. 877), and similar legislation based on lack of clarity and erroneous legal premises. Contacts in support of the informed consent legislation to give women truthful, non-misleading information prior to an abortion (not introduced). Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 109/H.R.627/H.R.2223/H.R.627/S.16) to prohibit the knowing transportation of a minor across a State line, with the intent that the minor obtain an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision Contacts in support of the Informed Consent Act (H.R. 1382/S.446) to criminalize any abortion or sterilization procedure performed without the informed consent of the person on whom such procedure is performed, and for other purposes. Contacts in support of the Protecting Life in Crisis Act (H.R. 28/S.87) which would extend existing Hyde Amendment protections to any COVID-19-related healthcare provisions. Contacts in support of PRENDA (S.86) to prohibit sex-selection abortions. Contacts in support of the Protecting Life and Integrity in Research Act of 2021(H.R. 563/S.77) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus, which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.92/H.R. 18). Contacts in support of defeating a Previous Question in order to initiate a procedure to provide for the immediate consideration of HR 18, the No Taxpayer Funding for Abortion Act, sponsored by Rep. Chris Smith (R-NJ). The Smith bill would make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 3755/H.R.8296) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts regarding the Care for Her Act (H.R. 5163) to extend services for pregnant women. Contacts regarding the Family Violence Prevention Act (H.R. 2119) in regards to abortion expanding provisions. Contacts in opposition to changes to Title X regulations which bar grantees from co-locating with abortion clinics or referring clients for abortions including support of a CRA overturning Biden administration regulation (S.J.Res. 41/H.J.Res. 76). Contacts in support of the Simon Crosier Act (H.R. 5656) which requires certain policies to be in place relating to do-not-resuscitate orders or similar physicians orders for unemancipated minors receiving services. Contacts in support of the Pregnancy Loss Mental Health Research Act of 2021 (H.R. 5995) to provide research on, and services for, individuals with clinical mental health complications following a pregnancy loss. Contacts in support of Stopping Traffickers and Their Accomplices Act of 2022 (H.R.6536) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regards to Data Mapping to Save Moms Lives Act (H.R.1218) and impact on abortion reporting. No position taken this quarter. Contacts in support of the Protecting Girls with Turner Syndrome Act of 2022 (H.R.7179) which would prohibit the performance of an abortion on an unborn child due to a diagnosis of Turner syndrome. Contacts in regards to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to legislation (not introduced) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs. Contacts in regards to the Bipartisan Safer Communities Act (S.2938). No position taken. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women including (S. 4868/H.R. 8851 Providing for Life Act, H.R. 8384/S.4541 Standing with Moms Act, and others). Contacts in regards to violence directed at pro-life organizations, pregnancy resource centers, and churches related to Supreme Court action on the Dobbs case. Contacts in regards to the Central American Women and Children Protection Act of 2021 (H.R.4017). No position taken.
Client expense: $70,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Abortion-related provisions pertaining to modifying PL 111-148 are reported on the HCR (Health Issues) page. Contacts in support of the Pain-Capable Unborn Child Protection Act (S. 61/H.R. 1080), to protect pain-capable unborn children beginning at 20 weeks fetal age as well as similar legislation (not introduced). Contacts in support of the Dismemberment Ban Act (H.R. 558) to prohibit a physician from knowingly performing a dismemberment abortion. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 619/ S.123), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age, and ensure that such child is immediately admitted to a hospital, including a urging signing of a discharge petition. Contacts in support of the Conscience Protection Act (S.401), to enhance federal remedies for health-care providers who face government-based discrimination for non-participation in abortion. Contacts in support of similar House legislation. Contacts regarding legislation to defund certain abortion providers (S. 139/H.R. 541/S.1881/H.R. 188/S.95/H.R.2619) to prohibit federal funding to entities that do not certify the entities will not perform, or provide any funding to any other entity that performs, an abortion, with certain exceptions. Contacts regarding legislation to ensure affiliate rules in law are applied to abortion providers receiving Paycheck Protection Program (PPP) loans in violation of the law. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding the Pregnant Workers Fairness Act (H.R. 1065). No position taken. Contacts regarding the Violence Against Women Reauthorization Act of 2021 (H.R. 1620). No position taken. Contacts regarding legislation to improve abortion reporting (H.R. 581/H.R.343/H.R. 6702 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 705 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.552) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in opposition to agency action expanding the use of tissue from aborted babies. Contacts in regards to FDA oversight of prenatal testing products and efficacy. Contacts in support of legislation (H.R.243/S.88/H.R. 500) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in support of legislation dealing with the disposal of fetal remains (H.R. 555/ H.R. 620/S.293). Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486. Contacts in support of the Down Syndrome Discrimination by Abortion Prohibition Act (S.75/ H.R.532 ) to prohibit abortions on the basis that the unborn child has or may have Down syndrome. Contacts in support of the Support And Value Expectant (SAVE) Moms and Babies Act of 2021 (S.78 /H.R. 554) to prevent labeling changes for already approved abortion drugs; prevents providers from dispensing these abortion drugs remotely, by mail, or via telemedicine; and prevent the Food and Drug Administration (FDA) from approving new chemical abortion drugs. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act of 2021 (H.R.626/S. 3252) to prohibit abortionists from performing chemical abortions without being physically present. Contacts explaining nonsupport for the Life at Conception Act (S.99/H.R. 1011) and the Sanctity of Human Life Act (H.R. 877), and similar legislation based on lack of clarity and erroneous legal premises. Contacts in support of the Women's Right to Know Act (not introduced) to give women truthful, non-misleading information prior to an abortion. Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 109/H.R.627/H.R.2223/H.R.627/S.16) to prohibit the knowing transportation of a minor across a State line, with the intent that the minor obtain an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision Contacts in support of the Informed Consent Act (H.R. 1382/S.446) to criminalize any abortion or sterilization procedure performed without the informed consent of the person on whom such procedure is performed, and for other purposes. Contacts in support of the Protecting Life in Crisis Act (H.R. 28/S.87) which would extend existing Hyde Amendment protections to any COVID-19-related healthcare provisions. Contacts in support of PRENDA (S.86) to prohibit sex-selection abortions. Contacts in support of the Protecting Life and Integrity in Research Act of 2021(H.R. 563/S.77) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus, which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.92/H.R. 18). Contacts in support of defeating a Previous Question in order to initiate a procedure to provide for the immediate consideration of HR 18, the No Taxpayer Funding for Abortion Act, sponsored by Rep. Chris Smith (R-NJ). The Smith bill would make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 3755/H.R.8296) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts regarding the Care for Her Act (H.R. 5163) to extend services for pregnant women. Contacts regarding the Family Violence Prevention Act (H.R. 2119) in regards to abortion expanding provisions. Contacts in opposition to changes to Title X regulations which bar grantees from co-locating with abortion clinics or referring clients for abortions including support of a CRA overturning Biden administration regulation (S.J.Res. 41/H.J.Res. 76). Contacts in support of the Simon Crosier Act (H.R. 5656) which requires certain policies to be in place relating to do-not-resuscitate orders or similar physicians orders for unemancipated minors receiving services. Contacts in support of the Pregnancy Loss Mental Health Research Act of 2021 (H.R. 5995) to provide research on, and services for, individuals with clinical mental health complications following a pregnancy loss. Contacts in support of Stopping Traffickers and Their Accomplices Act of 2022 (H.R.6536) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regards to Data Mapping to Save Moms Lives Act (H.R.1218) and impact on abortion reporting. No position taken this quarter. Contacts in support of the Protecting Girls with Turner Syndrome Act of 2022 (H.R.7179) which would prohibit the performance of an abortion on an unborn child due to a diagnosis of Turner syndrome. Contacts in regards to legislation (not introduced) to abortion operations on Federal lands. Contacts in opposition to legislation (not introduced) to codify Roe v. Wade and subsequent cases. Contacts in support of legislation (not introduced) to enforce laws related to the illegal shipment of abortion drugs. Contacts in regards to the Bipartisan Safer Communities Act (S.2938). No position taken. Contacts in support of numerous pieces of legislation to make further resources, funding, and information available to pregnant women. Contacts in regards to violence directed at pro-life organizations, pregnancy resource centers, and churches related to Supreme Court action on the Dobbs case. Contacts in regards to the Central American Women and Children Protection Act of 2021 (H.R.4017). No position taken.
Client expense: $60,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Abortion-related provisions pertaining to modifying PL 111-148 are reported on the HCR (Health Issues) page. Contacts in support of the Pain-Capable Unborn Child Protection Act (S. 61/H.R. 1080), to protect pain-capable unborn children beginning at 20 weeks fetal age as well as similar legislation (not introduced). Contacts in support of the Dismemberment Ban Act (H.R. 558) to prohibit a physician from knowingly performing a dismemberment abortion. Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 619/ S.123), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age, and ensure that such child is immediately admitted to a hospital, including a urging signing of a discharge petition. Contacts in support of the Conscience Protection Act (S.401), to enhance federal remedies for health-care providers who face government-based discrimination for non-participation in abortion. Contacts in support of similar House legislation. Contacts regarding legislation to defund certain abortion providers (S. 139/H.R. 541/S.1881/H.R. 188/S.95/H.R.2619) to prohibit federal funding to entities that do not certify the entities will not perform, or provide any funding to any other entity that performs, an abortion, with certain exceptions. Contacts regarding legislation to ensure affiliate rules in law are applied to abortion providers receiving Paycheck Protection Program (PPP) loans in violation of the law. Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter. Contacts regarding the Pregnant Workers Fairness Act (H.R. 1065). No position taken. Contacts regarding the Violence Against Women Reauthorization Act of 2021 (H.R. 1620). No position taken. Contacts regarding legislation to improve abortion reporting (H.R. 581/H.R.343/H.R. 6702 and others not introduced). Contacts in support of the Heartbeat Bill (H.R. 705 and others not introduced) to prohibit abortions if a fetal heartbeat is detectable. Contacts in support of the Second Chance at Life Act (H.R.552) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind. Contacts in opposition to agency action expanding the use of tissue from aborted babies. Contacts in regards to FDA oversight of prenatal testing products and efficacy. Contacts in support of legislation (H.R.243/S.88/H.R. 500) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions. Contacts in support of legislation dealing with the disposal of fetal remains (H.R. 555/ H.R. 620/S.293). Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486. Contacts in support of the Down Syndrome Discrimination by Abortion Prohibition Act (S.75/ H.R.532 ) to prohibit abortions on the basis that the unborn child has or may have Down syndrome. Contacts in support of the Support And Value Expectant (SAVE) Moms and Babies Act of 2021 (S.78 /H.R. 554) to prevent labeling changes for already approved abortion drugs; prevents providers from dispensing these abortion drugs remotely, by mail, or via telemedicine; and prevent the Food and Drug Administration (FDA) from approving new chemical abortion drugs. Contacts in opposition to regulation to make abortion drugs available by telemedicine. Contacts in support of the Teleabortion Prevention Act of 2021 (H.R.626/S. 3252) to prohibit abortionists from performing chemical abortions without being physically present. Contacts explaining nonsupport for the Life at Conception Act (S.99/H.R. 1011) and the Sanctity of Human Life Act (H.R. 877) based on lack of clarity and erroneous legal premises. Contacts in support of the Women's Right to Know Act (not introduced) to give women truthful, non-misleading information prior to an abortion. Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 109/H.R.627/H.R.2223/H.R.627/S.16) to prohibit the knowing transportation of a minor across a State line, with the intent that the minor obtain an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision Contacts in support of the Informed Consent Act (H.R. 1382/S.446) to criminalize any abortion or sterilization procedure performed without the informed consent of the person on whom such procedure is performed, and for other purposes. Contacts in support of the Protecting Life in Crisis Act (H.R. 28/S.87) which would extend existing Hyde Amendment protections to any COVID-19-related healthcare provisions. Contacts in support of PRENDA (S.86) to prohibit sex-selection abortions. Contacts in support of the Protecting Life and Integrity in Research Act of 2021(H.R. 563/S.77) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion. Contacts in support of Protecting Life on College Campus, which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty. Contacts in support of the No Taxpayer Funding for Abortion Act (S.92/H.R. 18). Contacts in support of defeating a Previous Question in order to initiate a procedure to provide for the immediate consideration of HR 18, the No Taxpayer Funding for Abortion Act, sponsored by Rep. Chris Smith (R-NJ). The Smith bill would make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Contacts in opposition to the Women's Health Protection Act (H.R. 3577) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development. Contacts regarding the Care for Her Act (H.R. 5163) to extend services for pregnant women. Contacts regarding the Family Violence Prevention Act (H.R. 2119) in regards to abortion expanding provisions. Contacts in opposition to changes to Title X regulations which bar grantees from co-locating with abortion clinics or referring clients for abortions including support of a CRA overturning Biden administration regulation (S.J.Res. 41/H.J.Res. 76). Contacts in support of the Simon Crosier Act (H.R. 5656) which requires certain policies to be in place relating to do-not-resuscitate orders or similar physicians orders for unemancipated minors receiving services. Contacts in support of the Pregnancy Loss Mental Health Research Act of 2021 (H.R. 5995) to provide research on, and services for, individuals with clinical mental health complications following a pregnancy loss. Contacts in support of Stopping Traffickers and Their Accomplices Act of 2022 (H.R.6536) which would require abortionists to report reasonable suspicion of sex trafficking. Contacts in regards to Data Mapping to Save Moms Lives Act (H.R.1218) and impact on abortion reporting. No position taken this quarter. Contacts in support of the Protecting Girls with Turner Syndrome Act of 2022 (H.R.7179) which would prohibit the performance of an abortion on an unborn child due to a diagnosis of Turner syndrome.
Client expense: $80,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Abortion-related provisions pertaining to modifying PL 111-148 are reported on the HCR (Health Issues) page.
Contacts in support of the Pain-Capable Unborn Child Protection Act (S. 61/H.R. 1080), to protect pain-capable unborn children beginning at 20 weeks fetal age.
Contacts in support of the Dismemberment Ban Act (H.R. 558) to prohibit a physician from knowingly performing a dismemberment abortion.
Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 619/ S.123), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age, and ensure that such child is immediately admitted to a hospital, including a urging signing of a discharge petition.
Contacts in support of the Conscience Protection Act (S.401), to enhance federal remedies for health-care providers who face government-based discrimination for non-participation in abortion. Contacts in support of similar House legislation.
Contacts regarding legislation to defund certain abortion providers (S. 139/H.R. 541/S.1881/H.R. 188/S.95/H.R.2619) to prohibit federal funding to entities that do not certify the entities will not perform, or provide any funding to any other entity that performs, an abortion, with certain exceptions.
Contacts regarding legislation to ensure affiliate rules in law are applied to abortion providers receiving Paycheck Protection Program (PPP) loans in violation of the law.
Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter.
Contacts regarding the Pregnant Workers Fairness Act (H.R. 1065). No position taken.
Contacts regarding the Violence Against Women Reauthorization Act of 2021 (H.R. 1620). No position taken.
Contacts regarding legislation to improve abortion reporting (H.R. 581/H.R.343 and others not introduced).
Contacts in support of the Heartbeat Bill (H.R. 705) to prohibit abortions if a fetal heartbeat is detectable.
Contacts in support of the Second Chance at Life Act (H.R.552) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind.
Contacts in opposition to agency action expanding the use of tissue from aborted babies.
Contacts in support of legislation (H.R.243/S.88/H.R. 500) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions.
Contacts in support of legislation dealing with the disposal of fetal remains (H.R. 555/ H.R. 620/S.293).
Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486.
Contacts in support of the Down Syndrome Discrimination by Abortion Prohibition Act (S.75/ H.R.532 ) to prohibit abortions on the basis that the unborn child has or may have Down syndrome.
Contacts in support of the Support And Value Expectant (SAVE) Moms and Babies Act of 2021 (S.78 /H.R. 554) to prevent labeling changes for already approved abortion drugs; prevents providers from dispensing these abortion drugs remotely, by mail, or via telemedicine; and prevent the Food and Drug Administration (FDA) from approving new chemical abortion drugs.
Contacts in support of the Teleabortion Prevention Act of 2021 (H.R.626/S. 3252) to prohibit abortionists from performing chemical abortions without being physically present.
Contacts explaining nonsupport for the Life at Conception Act (S.99/H.R. 1011) and the Sanctity of Human Life Act (H.R. 877) based on lack of clarity and erroneous legal premises.
Contacts in support of the Women's Right to Know Act (not introduced) to give women truthful, non-misleading information prior to an abortion.
Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 109/H.R.627/H.R.2223/H.R.627/S.16) to prohibit the knowing transportation of a minor across a State line, with the intent that the minor obtain an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision
Contacts in support of the Informed Consent Act (H.R. 1382/S.446) to criminalize any abortion or sterilization procedure performed without the informed consent of the person on whom such procedure is performed, and for other purposes.
Contacts in support of the Protecting Life in Crisis Act (H.R. 28/S.87) which would extend existing Hyde Amendment protections to any COVID-19-related healthcare provisions.
Contacts in support of PRENDA (S.86) to prohibit sex-selection abortions.
Contacts in support of the Protecting Life and Integrity in Research Act of 2021(H.R. 563/S.77) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion.
Contacts in support of Protecting Life on College Campus, which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty.
Contacts in support of the No Taxpayer Funding for Abortion Act (S.92/H.R. 18). Contacts in support of defeating a Previous Question in order to initiate a procedure to provide for the immediate consideration of HR 18, the No Taxpayer Funding for Abortion Act, sponsored by Rep. Chris Smith (R-NJ). The Smith bill would make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions.
Contacts in opposition to the Women's Health Protection Act (H.R. 3577) which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development.
Contacts regarding the Care for Her Act (H.R. 5163) to extend services for pregnant women.
Contacts regarding the Family Violence Prevention Act (H.R. 2119) in regards to abortion expanding provisions.
Contacts in opposition to changes to Title X regulations which bar grantees from co-locating with abortion clinics or referring clients for abortions.
Contacts in support of the Simon Crosier Act (H.R. 5656) which requires certain policies to be in place relating to do-not-resuscitate orders or similar physicians orders for unemancipated minors receiving services.
Contacts in support of the Pregnancy Loss Mental Health Research Act of 2021 (H.R. 5995) to provide research on, and services for, individuals with clinical mental health complications following a pregnancy loss.
Client expense: $60,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Abortion-related provisions pertaining to modifying PL 111-148 are reported on the HCR (Health Issues) page.
Contacts in support of the Pain-Capable Unborn Child Protection Act (S. 61/H.R. 1080), to protect pain-capable unborn children beginning at 20 weeks fetal age.
Contacts in support of the Dismemberment Ban Act (H.R. 558) to prohibit a physician from knowingly performing a dismemberment abortion.
Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 619/ S.123 ), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age, and ensure that such child is immediately admitted to a hospital, including a urging signing of a discharge petition.
Contacts in support of the Conscience Protection Act (S.401), to enhance federal remedies for health-care providers who face government-based discrimination for non-participation in abortion. Contacts in support of similar House legislation.
Contacts regarding legislation to defund certain abortion providers (S. 139/H.R. 541/S.1881/H.R. 188/S.95/H.R.2619) to prohibit federal funding to entities that do not certify the entities will not perform, or provide any funding to any other entity that performs, an abortion, with certain exceptions.
Contacts regarding legislation (not introduced) to ensure affiliate rules in law are applied to abortion providers receiving Paycheck Protection Program (PPP) loans in violation of the law.
Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter.
Contacts regarding the Pregnant Workers Fairness Act (H.R. 1065). No position taken.
Contacts regarding the Violence Against Women Reauthorization Act of 2021 (H.R. 1620 ). No position taken.
Contacts regarding legislation to improve abortion reporting (H.R. 581/H.R.343 and others not introduced).
Contacts in support of the Heartbeat Bill (H.R. 705) to prohibit abortions if a fetal heartbeat is detectable.
Contacts in support of the Second Chance at Life Act (H.R.552) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind.
Contacts in opposition to agency action expanding the use of tissue from aborted babies.
Contacts in support of legislation (H.R.243/S.88/H.R. 500) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions.
Contacts in support of legislation dealing with the disposal of fetal remains (H.R. 555/ H.R. 620/S.293).
Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486.
Contacts in support of the Down Syndrome Discrimination by Abortion Prohibition Act (S.75/ H.R.532 ) to prohibit abortions on the basis that the unborn child has or may have Down syndrome.
Contacts in support of the Support And Value Expectant (SAVE) Moms and Babies Act of 2021 (S.78 /H.R. 554) to prevent labeling changes for already approved abortion drugs; prevents providers from dispensing these abortion drugs remotely, by mail, or via telemedicine; and prevent the Food and Drug Administration (FDA) from approving new chemical abortion drugs.
Contacts in support of the Teleabortion Prevention Act of 2021 (H.R.626/S. 3252) to prohibit abortionists from performing chemical abortions without being physically present.
Contacts explaining nonsupport for the Life at Conception Act (S.99/H.R. 1011) and the Sanctity of Human Life Act (H.R. 877) based on lack of clarity and erroneous legal premises.
Contacts in support of the Women's Right to Know Act (not introduced) to give women truthful, non-misleading information prior to an abortion.
Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 109/H.R.627/H.R.2223/H.R.627/S.16) to prohibit the knowing transportation of a minor across a State line, with the intent that the minor obtain an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision
Contacts in support of the Informed Consent Act (H.R. 1382/S.446) to criminalize any abortion or sterilization procedure performed without the informed consent of the person on whom such procedure is performed, and for other purposes.
Contacts in support of the Protecting Life in Crisis Act (H.R. 28/S.87) which would extend existing Hyde Amendment protections to any COVID-19-related healthcare provisions.
Contacts in support of PRENDA (S.86) to prohibit sex-selection abortions.
Contacts in support of the Protecting Life and Integrity in Research Act of 2021(H.R. 563/S.77) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion.
Contacts in support of Protecting Life on College Campus, which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty.
Contacts in support of the No Taxpayer Funding for Abortion Act (S.92/H.R. 18). Contacts in support of defeating a Previous Question in order to initiate a procedure to provide for the immediate consideration of HR 18, the No Taxpayer Funding for Abortion Act, sponsored by Rep. Chris Smith (R-NJ). The Smith bill would make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions.
Contacts in opposition to the Women's Health Protection Act (H.R. 3577)which would enshrine into law abortion-on-demand and would overturn existing pro-life laws and prevent new protective laws from being enacted at the state and federal levels. This bill seeks to strip away from elected lawmakers the ability to provide even the most minimal protections for unborn children, at any stage of their pre-natal development.
Contacts regarding the Care for Her Act (H.R. 5163) to extend services for pregnant women.
Contacts regarding the Family Violence Prevention Act (H.R. 2119) in regards to abortion expanding provisions.
Contacts in opposition to changes to Title X regulations which bar grantees from co-locating with abortion clinics or referring clients for abortions.
Cited source text, amounts, lobbyists, and targets
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Abortion-related provisions pertaining to modifying PL 111-148 are reported on the HCR (Health Issues) page.
Contacts in support of the Pain-Capable Unborn Child Protection Act (S. 61/H.R. 1080), to protect pain-capable unborn children beginning at 20 weeks fetal age.
Contacts in support of the Dismemberment Ban Act (H.R. 558) to prohibit a physician from knowingly performing a dismemberment abortion.
Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 619/ S.123 ), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age, and ensure that such child is immediately admitted to a hospital, including a urging signing of a discharge petition.
Contacts in support of the Conscience Protection Act (S.401), to enhance federal remedies for health-care providers who face government-based discrimination for non-participation in abortion. Contacts in support of similar House legislation.
Contacts regarding legislation to defund certain abortion providers (S. 139/H.R. 541/S.1881/H.R. 188/S.95/H.R.2619) to prohibit federal funding to entities that do not certify the entities will not perform, or provide any funding to any other entity that performs, an abortion, with certain exceptions.
Contacts regarding legislation (not introduced) to ensure affiliate rules in law are applied to abortion providers receiving Paycheck Protection Program (PPP) loans in violation of the law.
Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter.
Contacts regarding the Pregnant Workers Fairness Act (H.R. 1065). No position taken.
Contacts regarding the Violence Against Women Reauthorization Act of 2021 (H.R. 1620 ). No position taken.
Contacts in opposition to the Paycheck Fairness Act (H.R. 7) because the legislation addresses discrimination based on sex, and there is no rule of construction that would make this legislation abortion-neutral, it is likely that it could be used to sue employers for a lack of elective abortion coverage. Letter sent to House April 13, 2021 and to the Senate June 8, 2021.
Contacts regarding legislation to improve abortion reporting (H.R. 581/H.R.343 and others not introduced).
Contacts in support of the Heartbeat Bill (H.R. 705) to prohibit abortions if a fetal heartbeat is detectable.
Contacts in support of the Second Chance at Life Act (H.R.552) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind.
Contacts in opposition to agency action expanding the use of tissue from aborted babies.
Contacts in support of legislation (H.R.243/S.88/H.R. 500) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions.
Contacts in support of legislation dealing with the disposal of fetal remains (H.R. 555/ H.R. 620/S.293).
Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486.
Contacts in support of the Down Syndrome Discrimination by Abortion Prohibition Act (S.75/ H.R.532 ) to prohibit abortions on the basis that the unborn child has or may have Down syndrome.
Contacts in support of the Support And Value Expectant (SAVE) Moms and Babies Act of 2021 (S.78 /H.R. 554) to prevent labeling changes for already approved abortion drugs; prevents providers from dispensing these abortion drugs remotely, by mail, or via telemedicine; and prevent the Food and Drug Administration (FDA) from approving new chemical abortion drugs.
Contacts in support of the Teleabortion Prevention Act of 2021 (H.R.626/S. 3252) to prohibit abortionists from performing chemical abortions without being physically present.
Contacts explaining nonsupport for the Life at Conception Act (S.99/H.R. 1011) and the Sanctity of Human Life Act (H.R. 877) based on lack of clarity and erroneous legal premises.
Contacts in support of the Women's Right to Know Act (not introduced) to give women truthful, non-misleading information prior to an abortion.
Contacts in support of the Protecting Life in Foreign Assistance Act (S.137/H.R.534) to would ensure that no funds may be made available to foreign non-governmental organizations, multi-lateral nonprofits, and quasi-autonomous non-governmental organizations that perform abortions, counsel for abortion, lobby for abortion policies or expanded access, or provide funding or resources for any entity, including domestic non-governmental organizations and non-profits, that perform abortions abroad.
Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 109/H.R.627/H.R.2223/H.R.627/S.16) to prohibit the knowing transportation of a minor across a State line, with the intent that the minor obtain an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision
Contacts in support of the Informed Consent Act (H.R. 1382/S.446) to criminalize any abortion or sterilization procedure performed without the informed consent of the person on whom such procedure is performed, and for other purposes.
Contacts in support of the Protecting Life in Crisis Act (H.R. 28/S.87) which would extend existing Hyde Amendment protections to any COVID-19-related healthcare provisions.
Contacts in support of PRENDA (S.86) to prohibit sex-selection abortions.
Contacts in support of the Protecting Life and Integrity in Research Act of 2021(H.R. 563/S.77) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion.
Contacts in support of Protecting Life on College Campus, which would prohibit federal funds from being directed to institutions of higher education that offer abortion procedures and chemical abortion drugs to students and faculty.
Contacts in support of the No Taxpayer Funding for Abortion Act (S.92/H.R. 18). Contacts in support of defeating a Previous Question in order to initiate a procedure to provide for the immediate consideration of HR 18, the No Taxpayer Funding for Abortion Act, sponsored by Rep. Chris Smith (R-NJ). The Smith bill would make permanent and government-wide the Hyde Amendment, which prevents taxpayer dollars from being used to fund abortions. Letter sent to the House June 22, 2021.
Cited source text, amounts, lobbyists, and targets
For activity pertaining to abortion-related components of appropriations, see BUD (Budget/Appropriations) page. Abortion-related provisions pertaining to modifying PL 111-148 are reported on the HCR (Health Issues) page.
Contacts in support of the Pain-Capable Unborn Child Protection Act (S. 61/H.R. 1080), to protect pain-capable unborn children beginning at 20 weeks fetal age.
Contacts in support of the Dismemberment Ban Act (H.R. 558) to prohibit a physician from knowingly performing a dismemberment abortion.
Contacts in support of Born-Alive Abortion Survivors Protection Act (H.R. 619/ S.123 ), to require any health care practitioner who is present when a child is born alive following an abortion or attempted abortion to exercise the same degree of care as reasonably provided to any other child born alive at the same gestational age, and ensure that such child is immediately admitted to a hospital, including a urging signing of a discharge petition
Contacts in support of the No Taxpayer Funding for Abortion Act (S.92/H.R. 18) to codify government-wide policy against funding abortion.
Contacts in support of the Conscience Protection Act (S.401), to enhance federal remedies for health-care providers who face government-based discrimination for non-participation in abortion. Contacts in support of similar House legislation.
Contacts regarding legislation to defund certain abortion providers (S. 139/H.R. 541/S.1881/H.R. 188/S.95/H.R.2619) to prohibit federal funding to entities that do not certify the entities will not perform, or provide any funding to any other entity that performs, an abortion, with certain exceptions.
Contacts regarding legislation (not introduced) to ensure affiliate rules in law are applied to abortion providers receiving Paycheck Protection Program (PPP) loans in violation of the law.
Consultations regarding various bills to restrict abortion; no specific legislation endorsed during this quarter.
Contacts regarding the Pregnant Workers Fairness Act (H.R. 1065). No position taken.
Contacts regarding the Violence Against Women Reauthorization Act of 2021 (H.R. 1620 ). No position taken.
Contacts in opposition to the Paycheck Fairness Act (H.R. 7) because the legislation addresses discrimination based on sex, and there is no rule of construction that would make this legislation abortion-neutral, it is likely that it could be used to sue employers for a lack of elective abortion coverage.
Contacts regarding legislation to improve abortion reporting (H.R. 581/H.R.343 and others not introduced).
Contacts in support of the Heartbeat Bill (H.R. 705) to prohibit abortions if a fetal heartbeat is detectable.
Contacts in support of the Second Chance at Life Act (H.R.552) to ensure that a woman seeking a chemical abortion is informed that it may be possible to reverse the intended effects of the abortion if the woman changes her mind.
Contacts in opposition to agency action expanding the use of tissue from aborted babies.
Contacts in support of legislation (H.R.243/S.88/H.R. 500) to make changes to the Title X program to ensure it does not grant funding to abortion facilities, grantees do not co-locate with abortion clinics, and grantees are not required to refer clients for abortions.
Contacts in support of legislation dealing with the disposal of fetal remains (H.R. 555/ H.R. 620/S.293).
Contacts in opposition to agency action weakening regulation surrounding the use of mifepristone and RU-486.
Contacts in support of the Down Syndrome Discrimination by Abortion Prohibition Act (S.75/ H.R.532 ) to prohibit abortions on the basis that the unborn child has or may have Down syndrome.
Contacts in support of the Support And Value Expectant (SAVE) Moms and Babies Act of 2021 (S.78 /H.R. 554) to prevent labeling changes for already approved abortion drugs; prevents providers from dispensing these abortion drugs remotely, by mail, or via telemedicine; and prevent the Food and Drug Administration (FDA) from approving new chemical abortion drugs.
Contacts in support of the Teleabortion Prevention Act of 2021 (H.R.626/S. 3252) to prohibit abortionists from performing chemical abortions without being physically present.
Contacts explaining nonsupport for the Life at Conception Act (S.99/H.R. 1011) and the Sanctity of Human Life Act (H.R. 877) based on lack of clarity and erroneous legal premises.
Contacts in support of the Women's Right to Know Act (not introduced) to give women truthful, non-misleading information prior to an abortion.
Contacts in support of the Protecting Life in Foreign Assistance Act (S.137/H.R.534) to would ensure that no funds may be made available to foreign non-governmental organizations, multi-lateral nonprofits, and quasi-autonomous non-governmental organizations that perform abortions, counsel for abortion, lobby for abortion policies or expanded access, or provide funding or resources for any entity, including domestic non-governmental organizations and non-profits, that perform abortions abroad.
Contacts in support of the Child Interstate Abortion Notification Act and similar legislation (S. 109/H.R.627/H.R.2223/H.R.627/S.16) to prohibit the knowing transportation of a minor across a State line, with the intent that the minor obtain an abortion, and thereby in fact abridges the right of a parent of the minor under a law requiring parental involvement in a minors abortion decision
Contacts in support of the Informed Consent Act (H.R. 1382/S.446) to criminalize any abortion or sterilization procedure performed without the informed consent of the person on whom such procedure is performed, and for other purposes.
Contacts in support of the Protecting Life in Crisis Act (H.R. 28/S.87) which would extend existing Hyde Amendment protections to any COVID-19-related healthcare provisions.
Contacts in support of PRENDA (S.86) to prohibit sex-selection abortions.
Contacts in support of the Protecting Life and Integrity in Research Act of 2021(H.R. 563/S.77) to prohibit the Department of Health and Human Services from conducting or supporting any research that involves the use of human fetal tissue from an induced abortion.
Cited source text, amounts, lobbyists, and targets
General resource access (including leasing, permitting, interagency coordination, and allocation of agency resources)and royalty rates in priority areas for offshore oil, gas and wind and related economic, environmental, and national security benefits.
Hypothetical comprehensive legislation on offshore energy--Proposals including preserving access to the Central and Western Gulf of Mexico for oil and gas, the Atlantic for wind, and additional items related to wind including revenue share
Memoranda on theWithdrawal of Certain Areas of the United States Outer Continental Shelf from Leasing Disposition, 2020--Presidential withdrawals of acreage for energy leasing and potential avenues for reversal, including potential legislation or agency action.
S. 69, H.R. 552--Conservation Funding Protection Act--Provisions mandating lease sales and permitting decisions in the Central and Western Gulf of Mexico.
H.R. 1325--More Energy More Jobs Act--Discussed potential re-introduction of bill on offshore energy leasing.
Nomination of Rep. Deb Haaland as Secretary of the Department of Interior--Her positions on various natural resources and energy issues
Draft version of The Reinvesting in Shoreline Economies and Ecosystems (RISEE) --Language incorporating the COASTAL Act and OFFSHORE Acts from the 116th Congress regarding revenue sharing from energy in federal waters, and potential amendments related to offshore energy leasing
H.R. 8632 (in 116th)--Oceans Based Climate Solutions Act--Discussed bills potential reintroduction and various provisions impacting fossil fuel leasing and production or offshore wind, including possible amendments.
2019-2024 National Outer Continental Shelf Oil and Gas Leasing Draft Proposed Program--Importance of resource access
H.R. 218--Saving America's Energy Future Act--Provisions on resource access and energy leasing
BOEM 2020-057--South Fork Wind Farm and South Fork Export Cable Project Draft Environmental Impact Statement--Timely approval
BOEM 2021-0012--Final Environmental Impact Statement for Vineyard Wind LLC Proposed Wind Energy Facility Offshore Massachusetts--Timely approval and community impacts
DOI Order No. 3395--Temporary Suspension of Delegated Authority--Impact on timely leasing, permitting, and approvals of offshore oil and gas-related actions
EO 14008--Executive Order on Tackling The Climate Crisis At Home And Abroad--Impact on timely leasing, permitting, and approvals of offshore oil and gas-related actions, including previously planned March lease sale 257
DOI Order No. 3394--Establishment of New Department Leadership Team and Temporary Redelegation of Authority--Impact on timely permitting of offshore oil and gas-related actions
H.R. 519--Safeguarding Oil and Gas Leasing and Permitting Act of 2021--Provisions impacting offshore oil and gas leasing.
S. 76, H.R. 543--Protecting our Wealth of Energy Resources Act--Provisions impacting offshore oil and gas leasing.
H.R. 859--Protecting American Energy Jobs Act--Provisions impacting offshore oil and gas leasing.
American Jobs Plan or similar potential federal infrastructure package--Potential provisions related to funding ports improvements for facilitating offshore wind, funding or tax assistance related to the construction of domestic offshore wind-enabling vessels, interconnection of offshore wind into the domestic electrical grid, potential General discussion on provisions impacting offshore energy. Specific possible provisions include tax assistance for offshore wind, lending related to domestic renewable energy manufacturing, jobs training for renewable energy, and concerns related to tax provisions impacting offshore oil and gas.
Nomination of Elizabeth Klein as Deputy Secretary to the Department of Interior--Her positions on various natural resources and energy issues
Potential nomination of Thomas Beadreau to Deputy Secretary at the Department of Interior--His positions on various energy and natural resources issues.
Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Council on Disability, SENATE
Client expense: $60,000 · Firm income: Not reported
Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Council on Disability, SENATE
Client expense: $100,000 · Firm income: Not reported